CapitalWatch

New Horizon Health was China’s first cancer-screening device company to go public, and was once the envy of the industry as its revenue surged more than 20 times in the three years through 2023 and its gross margin jumped from 52% to 90%.

FAST NEWS: New Horizon Health CFO, auditor resign

The Latest: Cancer-screening device maker New Horizon Health Ltd. (6606.HK) announced Monday that Deloitte has resigned as its auditor, effective Sept. 9. Separately, the company said its CFO Gao Yu also announced…
6606.HK

Recent Articles

RELATED ARTICLES

  1. The provider of cancer-screening products issued a positive profit alert in January, but the full earnings report has yet to appear after auditors raised questions about the company’s revenues.
    New Horizon Health launches probe into disputed sales figures
    6606.HK
  2. Sinking Burning Rock faces de-listing. But could privatization bid come first?
    BNR.US
  3. Bayzed joins IPO quest as medical rivalry heats up
  4. China Renaissance Edges Closer to Trading Resumption Under New Chairman
    1911.HK
  5. Margins ring alarm bells as 160 Health readies IPO 
  6. Transsion dodges bullet with CFO’s release after two-week detention
    688036.SHG
  7. Dada Nexus rides closer to JD.com’s orbit with management shakeup
    DADA.US
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva